Hypertension Journal

FEBRUARY 21, 2024

Hypertension, Ahead of Print. Hypertension, a leading cause of cardiovascular disease and premature death, remains incompletely understood despite extensive research. Indeed, even though numerous drugs are available, achieving adequate blood pressure control remains a challenge, prompting recent interest in artificial intelligence.

Hypertension 45

Hypertension Blood Pressure Innovation Risk Factors 45

Cardiometabolic Health Congress

JULY 25, 2024

This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L. Innovations in Cardiorenal Metabolic Medicine The event will focus on the whole spectrum of cardiorenal metabolic disease, including obesity, diabetes, lipids, hypertension, and cardiorenal disease.

Education 100

Education Innovation Risk Factors Obesity 100

DAIC

FEBRUARY 18, 2025

Raj Makkar, MD, vice president of Cardiovascular Innovation and Intervention and the director of the Karsh Division of Interventional Cardiology in the Smidt Heart Institute at Cedars-Sinai, and his team of experts treat more than 10,000 patients every year.

Tricuspid 52

Tricuspid Open-Heart Surgery Quality of Life Anatomy 52

American College of Cardiology

NOVEMBER 5, 2024

After all, as the Framingham Heart Study clearly showed, obesity and overweight are significantly associated with a higher risk of hypertension, angina and coronary heart disease. The idea that obesity increases the risk of heart failure seems like an obvious conclusion.

Heart Failure 45

Heart Failure Innovation Angina Obesity 45

Wellnest

DECEMBER 18, 2023

These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies. But what is resistant hypertension, and why does it require renal denervation?

Hypertension 52

Hypertension Blood Pressure Ablation Reimbursement 52

DAIC

FEBRUARY 7, 2024

The framework outlines opportunities for the broader integration of the technology into the workflow for screening and diagnosing cardiovascular disease, using AFib and Hypertension as examples. As we progress, it is imperative to maintain vigilance, addressing potential pitfalls associated with these solutions.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

APRIL 1, 2024

“We are witnessing a paradigm shift in how valvular heart diseases are diagnosed and treated,” said Partho Sengupta , Henry Rutgers Professor of Cardiology and chief of the Division of Cardiovascular Disease and Hypertension at Rutgers Robert Wood Johnson Medical School. Is There Medication for Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

FEBRUARY 1, 2024

million, or 47% of adults are estimated to have hypertension.** Addressing strategies for companies in this industry, the market analysts offer two keys to driving future growth, writing: “Focusing on the development of innovative lipid-lowering drugs is an effective strategy for success in the Atherosclerosis Drugs Market.

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Strokes Stroke 104

Circulation

NOVEMBER 11, 2024

Introduction:Inflammation is a key driver in the development of pulmonary arterial hypertension (PAH). Recent studies have indicated that modulating the intestinal microbiome may be an innovative approach to mitigate systemic inflammation in PAH. Circulation, Volume 150, Issue Suppl_1 , Page A4142839-A4142839, November 12, 2024.

Pulmonary 40

Pulmonary Hypertension Innovation Exercise 40

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

Circulation: Cardiovascular Quality & Outcomes

MARCH 26, 2025

BACKGROUND:Remote health management programs utilizing evidence-based algorithm-driven virtual care solutions for chronic disease management offer a novel approach to addressing implementation gaps for conditions such as hypertension. Most patient participants were male (n=12) and identified their race and ethnicity as White (n=15).

Hypertension 40

Hypertension Blood Pressure Chronic Disease Innovation 40

ADN Center of Excellence

SEPTEMBER 2, 2024

Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving.

AFIB 59

AFIB Atrial Fibrillation Innovation Heart Rhythm 59

GEMMS

APRIL 3, 2025

GEMMS is committed to enhancing patient care through innovative solutions that improve engagement, streamline workflows, and support cardiovascular care. In 2025, the demand for telehealth capabilities will only continue to grow, especially in managing chronic conditions like hypertension and heart disease.

Technology 52

Technology Patient Care Education Innovation 52

DAIC

JUNE 27, 2024

Anumana has received FDA Breakthrough Device Designation for four of its algorithms: low ejection fraction, pulmonary hypertension , cardiac amyloidosis, and hyperkalemia. The companies will also work together to validate the clinical utility of the integrated solution and seek regulatory clearance to bring this technology to market.

Technology 105

Technology Heart Rhythm Innovation Heart Failure 105

MIBHS

JANUARY 31, 2025

Risk Reduction Data from wearables can identify potential risks, such as undiagnosed arrhythmias or hypertension, allowing healthcare teams to address these issues before surgery. By embracing this innovative approach, you can pave the way for a healthier heart and a brighter future.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

Cardiometabolic Health Congress

OCTOBER 25, 2024

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.

CME 64

CME Innovation Education Atherosclerosis 64

Journal of the American Heart Association

JANUARY 16, 2024

BackgroundSmartphone applications and wearable devices are promising mobile health interventions for hypertension self‐management. Journal of the American Heart Association, Volume 13, Issue 2 , January 16, 2024. However, most mobile health interventions fail to use contextual data, potentially diminishing their impact.

Blood Pressure 67

Blood Pressure Diet Innovation Hypertension 67

ADN Center of Excellence

SEPTEMBER 2, 2024

Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving.

AFIB 52

AFIB Atrial Fibrillation Innovation Heart Rhythm 52

Dr. S. Venkatesan MD

JANUARY 25, 2024

For the busy cardiologists, this will a be refreshing reminder, that there are other important organs and specialties do exist in medicine , with equal breakthroughs and Innovations. Baxdrostat, an Aldosterone synthase antagonist for treatment-resistant Hypertension, appears promising (BrigHTN).

Research 52

Research Article Document Public Health 52

Cardiometabolic Health Congress

DECEMBER 5, 2024

As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. Read the published study.

CME 52

CME Obesity Innovation Cardiovascular Disease 52

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

ADN Center of Excellence

OCTOBER 28, 2024

Some of the latest strategies include: Innovations in Thrombolysis and Clot Retrieval : Techniques such as tissue plasminogen activator (tPA) injections and mechanical thrombectomy are significantly improving recovery rates for ischemic stroke patients.

Strokes 59

Strokes Stroke Education Innovation 59

DAIC

FEBRUARY 12, 2024

CVRx is a commercial-stage medical device company focused on the developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area.

Heart Failure 104

Heart Failure Hospital Quality of Life Heart Attack 104

Circulation

NOVEMBER 11, 2024

Introduction/Background:The American Heart Association’s National Hypertension Control Initiative (NHCI) collaborated with health care professionals and public health advocates to facilitate listening sessions for learning collaboratives (LCs) to discuss ways to address hypertension (HTN) through Clinical-Community Linkages (CCL) in five regions.

Blood Pressure 40

Blood Pressure Public Health Hypertension Innovation 40

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

DAIC

FEBRUARY 16, 2024

By expanding our HeartRisk platform, we're not just innovating within traditional healthcare sectors but breaking new ground in diverse markets. The incarcerated population exhibits higher rates of cardiovascular risk factors, such as smoking and hypertension, compared to the general population.

Chronic Disease 91

Chronic Disease Heart Attack Heart attacks Heart Disease 91

DAIC

MAY 21, 2024

The study is the largest and most robust of its kind to date, examining 102,475 Hello Heart users with high BP (hypertension) between January 2018 and December 2022. Founded in 2013, Hello Heart is a digital leader in preventive heart health and a member of the American Heart Association’s Innovators’ Network. of their body weight.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

DAIC

DECEMBER 19, 2023

This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

Cardiometabolic Health Congress

AUGUST 8, 2024

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Cardiometabolic Health Congress

AUGUST 2, 2024

This innovative approach integrates personal data from multiple biological layers to design bespoke dietary plans, transcending the limitations of one-size-fits-all recommendations. This is particularly beneficial in managing conditions like hypertension, where precise control of dietary sodium intake is crucial.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Dr. S. Venkatesan MD

APRIL 18, 2024

May be, it will come soon in the innovative lanes of cardiology. This is to create a small regulatory orifice in the IAS ( A complicated term for a small ASD ) to decompress the LA and reduce pulmonary congestive symptoms. Curious minds might ask, can’t we decompress LV it self by creating a small VSD.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Pulmonary Congenital Heart Disease VSD 40

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

DAIC

FEBRUARY 12, 2024

CVRx is a commercial-stage medical device company focused on the developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area.

Heart Failure 52

Heart Failure Hospital Quality of Life Heart Attack 52

Dr. Smith's ECG Blog

DECEMBER 27, 2018

Cardiologs founder, Yann Flereau, was named by MIT as the European Innovator of the Year. But in a patient without any such symptoms — marked LVH in a patient with severe longstanding hypertension may sometimes produce very similar ST-T wave changes as are seen in Figure-1. What an honor. What do you think?

Chest Pain 40

Chest Pain Hypertension STEMI Heart Disease 40

The Beat Blog

MAY 2, 2023

4 Conditions such as Ischemic Heart Disease, Atrial Fibrillation, Hypertensive Heart Disease, and Ischemic Stroke make up almost 75% of the deaths due to cardiovascular disease. 5 These conditions, if detected and addressed early and appropriately, can be treated and prevented. Doing so also helps address socio-economic barriers.

Atrial Fibrillation 52

Atrial Fibrillation Cardiovascular Disease Technology Hospital 52